Unilever Outlines Strategy Behind $68 Billion GSK Consumer Healthcare Bid

Unilever Outlines Strategy Behind $68 Billion GSK Consumer Healthcare Bid

Unilever has outlined why it has tabled three bids, with the latest at around $68 billion, for the Consumer Healthcare division of GlaxoSmithKline (GSK). Following an “extensive” review, the British owner of Ben & Jerry’s, PG Tips, Dove and Lipton Tea has decided that its strategic direction should be to “materially expand” its health, beauty and hygiene offer.

0
Like
Save